• Aucun résultat trouvé

Therapeutic Synergy Between Antibiotics and Pulmonary Toll-Like Receptor 5 Stimulation in Antibiotic-Sensitive or -Resistant Pneumonia

N/A
N/A
Protected

Academic year: 2021

Partager "Therapeutic Synergy Between Antibiotics and Pulmonary Toll-Like Receptor 5 Stimulation in Antibiotic-Sensitive or -Resistant Pneumonia"

Copied!
14
0
0

Texte intégral

Loading

Références

Documents relatifs

To determine whether TLR4 was involved in AT fibrosis, we compared the expression of genes involved in tissue remodeling in C3H/HeJ mice carrying an inactivating mutation in the

TLR5 activation in MCF7 cells induced a single and sustained NF-κB translocation into the nucleus that resulted in high NF-κB transcription activity.. The overall magnitude of

Herein, we showed for the first time that FCGRT mRNA is down- regulated in non-small cell lung carcinoma (NSCLC) patients and that FCGRT mRNA levels in both NSCLC and

The main infection sites were the respiratory tract (21%) and urinary tract (17.1%) When we compared immunological parameters including cell counts determined by flow cytometry in

dermatomyositis, polymyositis and CADM can also be associated with other presentations of respiratory involvement, namely pulmonary arterial hypertension (PAH) [5], pleural disease

Our simulations and experimental results point to a potential role of TLR5 co-stimulatory signals in the activation and differentiation of CD4 + T cells through the

There was no signi fi cant difference between both alkaloids in regard to LPS and zymosan stimulation, while glaucine had higher suppressive effect on CpG-induced NO release compared

The immune response to Pseudomonas aeruginosa, Burkholderia cenocepacia, Bordetella bronchiseptica, or Legionella pneumophila is partly or fully recapitulated by